CITATIONS


JOP. J Pancreas (Online) 2003; 4(3):117-124.

Effects of the Imidazoline Binding Site Ligands, Idazoxan and Efaroxan, on the Viability of Insulin-Secreting BRIN-BD11 Cells

Gao H, Mourtada M, Morgan NG

Cellular Pharmacology Group, School of Life Sciences, Keele University. Staffs, United Kingdom


Cited by:

3

Lupu A, Popa I, Draghici C, et al. Disubstituted 2-imidazolinic 1,2,d erivatives. Technological study. Revista de Chimie 2007; 58 (7): 636-639. [More details]

2

Piletz JE, Wang G, Zhu H. Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. Ann N Y Acad Sci 2003; 1009:392-9. [More details]

1

Rustenbeck I, Krautheim A, Jörns A, Steinfelder HJ. Beta-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues. Biochemical Pharmacology 2004; 67:1733-41. [More details]